Federal inventionINDEX July 2026: 1.28% (B- grade)
The inventionINDEX measures innovation output by comparing GDP growth with patent production growth.
Anything over C grade is positive sentiment; anything under C is negative outlook/sentiment. Using that sentiment, it is possible to observe trends over time, and also compare states/countries. In doing so, we can predict which states have the best chance to recover economically from the pandemic (or any other economic incident that may occur).
Historical Federal inventionINDEX Scores
The Federal inventionINDEX score for the past 12 months is shown in the table below.
| Month | inventionINDEX SCORE |
|---|---|
| July 2026 | 1.28% |
| June 2026 | 1.65% |
| May 2026 | 1.36% |
| April 2026 | 1.05% |
| March 2026 | 1.62% |
| February 2026 | 1.38% |
| January 2026 | 1.22% |
| December 2025 | 1.54% |
| November 2025 | 1.37% |
| October 2025 | 1.35% |
| September 2025 | 1.66% |
| August 2025 | 1.43% |
| July 2025 | 1.95% |
The Federal inventionINDEX score for July 2026 stands at 1.28% with a B- rating, placing it below the historical dataset average of 1.54% and marking a pull-back from June 2026’s score of 1.65% (A-). Over the evaluated timeline spanning July 2021 through July 2026, score performance ranges from a peak of 2.31% (A+) in October 2023 to a historic low of 1.05% (C) in April 2026. While performance throughout 2023 averaged 1.63% with multiple A-tier evaluations, the mean score for 2026 has slowed to 1.37%, reflecting broader macro-level moderation across recent quarters after sustained periods of elevated metrics in preceding years.
Higher inventionINDEX grades yield substantial advantages across the institutional and economic landscape. When scores reach upper tiers such as A+ or A, as demonstrated in October 2023 (2.31%) or August 2023 (2.20%), the index signals robust intellectual property output, streamlined commercialization pipelines, and heightened efficiency in research allocation. Stronger ratings enhance investor confidence, attract venture capital, and validate strategic policy measures designed to foster technological advancement. Elevated scores also indicate effective technology transfer mechanisms, encouraging ongoing cross-sector collaboration and positioning participating entities for sustainable long-term competitiveness.
Conversely, lower inventionINDEX scores expose vulnerabilities within the underlying innovation framework. Trajectories dipping into C+ or C ratings, such as January 2026 (1.22%) and April 2026 (1.05%), point to reduced patent commercialization, administrative bottlenecks, or constrained research funding. Persistent weakness in scores compresses capital inflows and indicates potential market friction in bringing new concepts to commercial maturity. Over time, depressed evaluation metrics can weaken strategic advantage, slow regulatory approvals, and signal operational inefficiencies that hinder systemic productivity.
Navigating the variance between historical highs and lower modern baselines requires targeted structural focus. Reversing the recent deceleration observed in 2026 back toward peak thresholds will depend on optimizing resource distribution, simplifying compliance frameworks, and incentivizing private sector R&D initiatives. By systematically addressing the factors that drive score fluctuations, institutions can establish a more consistent trajectory toward top-tier performance, reinforcing economic resilience and sustaining momentum across future reporting periods.
Discussion:
In July, the Federal inventionINDEX scored a positive sentiment which was lower than the previous year’s average and underperformed the downward trend for the year. This is similar to the prior 12 months, which experienced a slight downward trend.
As the economy continues to stabilize in the post-pandemic era, it remains uncertain whether any backlog of applications still exists or if the department has returned to normal processing timelines. The inventionINDEX could also be affected by lingering consequences from the pandemic, such as company closures, reduced workforces, and limited R&D capabilities, which may still be impacting current operations.
Learn More:
Are you thinking of patenting any of your bright ideas? Did you know your research work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? To find out more, please check out our free online eligibility test.
Swanson Reed provides R&D tax credit consulting and advisory services to companies in all 50 U.S. States.
Feel free to book a quick teleconference with one of R&D tax specialists if you would like to learn more about R&D tax credit opportunities.
Who We Are:
Swanson Reed is the largest Specialist R&D tax credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D tax credit consulting services to our clients. We have been exclusively providing R&D tax credit claim preparation and audit compliance solutions for over 30 years.
Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/free-webinars or contact your usual Swanson Reed representative.